About AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org (https://geriatricscareonline.org)
Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Cindy Carlsson , Professor of Medicine Geriatrics at the University of Wisconsin School of Medicine and Public Health and staff physician at the Madison VA Hospital Geriatric Research, Education and Clinical Center (GRECC), Madison VA Memory Assessment Clinic, as they the role of fluid biomarkers in the Diagnosis of Alzheimer’s Disease. To view a transcript click here, then select the transcr...
17 Oct 2025
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
17 Oct 2025
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheim...
16 Oct 2025
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What ...
15 Oct 2025
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of...
15 Oct 2025
Pathology and Diagnostic Frameworks for Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-director of the Duke/UNC Alzheimer’s Disease Research Center, as they discuss Pathology and Diagnostic Frameworks for Alzheimer Disease. To view a transcript click here then select the transcript tab.
15 Oct 2025
Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Disease (CEAD), Director of University Geriatricians, and Chair of the Department of Geriatrics at SUNY Upstate University Hospital; and Dr. Alejandra Sanchez Lopez, Assistant Clinical Professor of Neurology and Geriatric Medicine at UCLA, as they discuss ...
15 Oct 2025
Evaluation of Cognition and Cognitive Disorder
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Director, Johns Hopkins Memory and Alzheimer's Treatment Center and; Dr. Mfon E. Umoh, Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, as they discuss Evaluation of Cognition and ...
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Contact AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
